FINWIRES · TerminalLIVE
FINWIRES

PreveCeutical Medical Seeking $1 Million in a Non-Brokered Private Placement

-- PreveCeutical Medical (PREV.CN) on Wednesday said it will raise up to $1 million from a non-brokered private placement of share units.

The company is offering to place up to 40-million units priced at $0.025 and made up of a share and one half of a two-year warrant to buy a share for $0.05.

Proceeds from the offering will be used for short loan repayments, audit, accounting and legal fees, patents and further studies and analysis of rodents and tissues, as well as general working-capital needs.

Shares of the company were last seen down $0.01 to $0.015 on the Canadian Securities Exchange.

Price: $0.02, Change: $-0.01, Percent Change: -40.00%

Related Articles

Australia

UBS Adjusts Price Target on Tapestry to $142 From $141, Maintains Neutral Rating

Tapestry (TPR) has an average rating of overweight and mean price target of $165.53, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $148.33, Change: $+2.15, Percent Change: +1.47%

$TPR
Australia

Oppenheimer Adjusts Boston Scientific Price Target to $90 From $100, Maintains Outperform Rating

Boston Scientific (BSX) has an average rating of Buy and mean price target of $87.23, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $65.88, Change: $+1.01, Percent Change: +1.55%

$BSX
Research

B. Riley Downgrades Century Communities to Neutral From Buy, Cuts Price Target to $64 From $75

Price: $56.30, Change: $-7.53, Percent Change: -11.80%

$CCS